“An AVID Dissent”: Commentary
- 1 November 1994
- journal article
- editorial
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 17 (11) , 1712-1713
- https://doi.org/10.1111/j.1540-8159.1994.tb03737.x
Abstract
Although current data suggest that the ICD is effective, the inherent unreliability of available nonrandomized observational studies make randomized trials of the ICD, such as AVID, CIDS, and CASH, ethically justified and highly desirable. Reasonable decisions regarding patient eligibility and the primary endpoint have been made by all three studies. When completed, these studies should have sufficient power to provide a clear answer as to whether or not the ICD reduces death in our highest risk patients.Keywords
This publication has 6 references indexed in Scilit:
- Canadian Implantable Defibrillator Study (CIDS): Study design and organizationThe American Journal of Cardiology, 1993
- Preliminary results of the Cardiac Arrest Study Hamburg (CASH)The American Journal of Cardiology, 1993
- Standardized Reporting of ICD Patient Outcome: The Report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9–10, 1993Pacing and Clinical Electrophysiology, 1993
- Survival after implantation of the cardioverter defibrillatorThe American Journal of Cardiology, 1992
- Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillatorJournal of the American College of Cardiology, 1989